National Heart, Lung, and Blood Institute (NHLBI), NIH Grants

Open National Heart, Lung, and Blood Institute (NHLBI), NIH grants

• NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)

  Deadline: Sep 8, 2028open

  NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Provi...

  health_disparitiescardiovascularinfectious_diseaseomicsheart disease

• Sickle Cell Disease Advisory Committee

  open

  Sickle Cell Disease Advisory Committee is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Provides recommendations on research pr...

  sickle_cellhealth_disparitiesclinical_researchbiomedical_researchsickle cell disease

• Sickle Cell Disease Implementation Consortium (SCDIC)

  open

  Sickle Cell Disease Implementation Consortium (SCDIC) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Funds research to improv...

  sickle_cellclinical_researchhealth_disparitiesbiomedical_researchsickle cell disease

• Sickle Cell Disease in Sub-Saharan Africa Collaborative Consortium

  open

  Sickle Cell Disease in Sub-Saharan Africa Collaborative Consortium is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Supports re...

  sickle_cellglobal_healthclinical_researchpublic_healthsickle cell disease

• Translational Blood Science and Resources

  open

  Translational Blood Science and Resources is a grant from the National Heart, Lung, and Blood Institute (NHLBI), NIH that funds translational research...

  biomedical_researchclinical_researchprecision_medicinesmall_businessworkforce_development

• Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

  open

  The Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials is a grant from the National Heart, Lung, and Blood Institute (NHLB...

  clinical_researchcardiovasculardata_sciencehealth_disparitiesclinical trials

• NHLBI Supplement to the NIH Policy for Data Management and Sharing

  open

  The NHLBI Supplement to the NIH Policy for Data Management and Sharing is a policy framework from the National Heart, Lung, and Blood Institute (NHLBI...

  cardiovascularbiomedical_researchdata_sciencedata managementdata sharing

• Adult and Pediatric Cardiac Research

  open

  Adult and Pediatric Cardiac Research grants are administered by the National Heart, Lung, and Blood Institute (NHLBI) at NIH to fund research on heart...

  cardiovascularclinical_researchbiomedical_researchpublic_healthheart disease

• Limited Competition for the Cure Sickle Cell Initiative Centers (UG3/UH3)

  open

  Limited Competition for the Cure Sickle Cell Initiative Centers (UG3/UH3) is a grant from the National Heart, Lung, and Blood Institute (NHLBI) at NIH...

  sickle_cellbiomedical_researchclinical_researchhealth_disparitiessickle cell disease

• Sickle Cell Disease Research Funding Opportunities

  open

  Sickle Cell Disease Research Funding Opportunities is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. The NHLBI consistently fund...

  health_disparitiessickle_cellpublic_healthsickle cellgene therapy

• NHLBI Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

  open

  NHLBI Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) is sponsored by National Hear...

  biomedical_researchclinical_researchprecision_medicinecardiovascularhealth_disparities

• NHLBI-AI Enabled Precision Medicine Initiative for HLBS Health

  open

  NHLBI-AI Enabled Precision Medicine Initiative for HLBS Health is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. This initiative...

  artificial_intelligenceai_healthcareprecision_medicinecardiovascularbiomedical_research

• NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

  open

  NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) is sponsored by National Heart, Lung, and Blood ...

  cardiovascularbiomedical_researchclinical_researchprecision_medicineomics data

• NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)

  open

  NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) is sponsored by National Heart, ...

  clinical_researchbiomedical_researchhealth_disparitiespostdoctoral fellowshipcareer transition

• Mentored Patient-Oriented Research Career Development Award (K23)

  open

  Mentored Patient-Oriented Research Career Development Award (K23) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. This award s...

  clinical_researchcardiovascularhealth_disparitiesbiomedical_researchpatient-oriented research

• Lung Vascular Biology Research

  open

  Lung Vascular Biology Research is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Supports research into the pathogenesis and pha...

  cardiovascularbiomedical_researchprecision_medicinepulmonary hypertensionright ventricular disease

• Neonatal and Pediatric Lung Disease / Critical Care Program

  open

  Neonatal and Pediatric Lung Disease / Critical Care Program is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. Funds research on ...

  health_disparitiesclinical_researchmaternal_healthcardiovascularneonatal lung disease

• Sickle Pan-African Research Consortium (SPARCO) Collaborative Sites (U01 Clinical Trial Not Allowed)

  open

  Sickle Pan-African Research Consortium (SPARCO) Collaborative Sites (U01 Clinical Trial Not Allowed) is sponsored by National Heart, Lung, and Blood I...

  sickle_cellclinical_researchglobal_healthbiomedical_researchsickle cell disease

• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

  open

  NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) is sponsored by National Heart, Lung, and B...

  clinical_researchcardiovascularinfectious_diseasepublic_healthearly-phase clinical trials

How to apply for National Heart, Lung, and Blood Institute (NHLBI), NIH grants

Most National Heart, Lung, and Blood Institute (NHLBI), NIH applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.